response to type I IFNs within the CNS might provide an approach to reverse or slow down age-associated cognitive decline or other pathological conditions associated with chronic IFN-I within the CNS.
30. M. Wichers, M. Maes, Int. J. Neuropsychopharmacol. 5, 375-388 (2002 
T CELL MEMORY
A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells
Norifumi Iijima and Akiko Iwasaki* CD8 tissue-resident memory T (T RM ) cells provide efficient local control of viral infection, but the role of CD4 T RM is less clear. Here, by using parabiotic mice, we show that a preexisting pool of CD4 T RM cells in the genital mucosa was required for full protection from a lethal herpes simplex virus 2 (HSV-2) infection. Chemokines secreted by a local network of macrophages maintained vaginal CD4 T RM in memory lymphocyte clusters (MLCs), independently of circulating memory T cells. CD4 T RM cells within the MLCs were enriched in clones that expanded in response to HSV-2. Our results highlight the need for vaccine strategies that enable establishment of T RM cells for protection from a sexually transmitted virus and provide insights as to how such a pool might be established.
E ffector memory T cells circulate throughout the peripheral tissues, and although they are sufficient to provide protection against systemic infections (1-4), they cannot control infection localized to peripheral tissues (4) (5) (6) . After viral skin infection, CD8 tissue-resident memory T (T RM ) cells control infection more efficiently than circulating CD8 T cells (7) (8) (9) (10) and recruit circulating T cells to the sites of infection (11) . In contrast to CD8 T RM cells, little is known regarding the existence or importance of CD4 T RM cells. Unlike CD8 T cells, memory CD4 T cells readily traffic through circulation to provide protection at distal sites (12) . Respiratory infection with influenza virus induces protective CD4 T cells capable of migrating and establishing residency in the lung (13) . However, to what extent resident versus circulating memory CD4 T cells are required for protection of the host and the mechanism by which such a memory pool is maintained are unclear.
To address these questions, we used a mouse model of genital herpes. Intravaginal (ivag) immunization with an attenuated herpes simplex virus 2 (HSV-2) strain [thymidine kinase-negative (TK) -HSV-2] results in complete protection from secondary challenge with wild-type (WT) HSV-2 (14) . TK -HSV-2 replicates in the vaginal keratinocytes and establishes latent infection in the dorsal root ganglia but does not reactivate (15) . The protective memory response to HSV-2 vaginal challenge requires CD4 T cells that secrete the cytokine interferon-g (IFN-g) but does not require either CD8 T cells or B cells (16) . Although all routes of immunization induced systemic CD4 T cell responses, only ivag immunization with TK -HSV-2 recruited significant numbers of viral-specific CD4 T cells to the vagina (17, 18) and conferred protection against lethal disease ( fig. S1 ), which indicated that the local immunization is required to mount protective immunity.
To examine the selective ability of local immunization to confer protective immunity, we used parabiotic mice. Full chimerism was achieved in systemic circulation within 2 weeks of parabiosis ( fig. S2) (19) . The vaginal memory pool, analyzed 6 weeks after parabiosis of ivag TK -HSV-2 immune pairs, was largely disconnected from the rest of the circulation (Fig. 1A) . Host-derived CD4 T RM cells were mainly distributed within memory lymphocyte clusters (MLCs), whereas the rare donor-derived circulating CD4 T cells were found at the periphery of the MLCs (Fig. 1B ). In contrast, CD8 T RM cells resided within the epithelium and within the MLCs, and circulating CD8 T cells were rarely found (Fig. 1B) T RM cells residing within the MLCs (Fig. 1C) . Only a small subset of CD4 T RM cells expressed CD103 ( fig. S4 , B and C), a molecule important for CD8 T RM cell survival within the epithelia (23) .
Next, to investigate whether a continuous supply of circulating lymphocytes is required to maintain the vaginal memory pool, mice immunized intravaginally were treated with FTY720, an antagonist of sphingosine-1-phosphate receptor 1 (S1PR1) that blocks lymphocyte egress from lymph nodes. Although circulating lymphocytes were depleted from peripheral blood was stained with antibody against CD4. CD4 + cells in MLCs were collected by laser capture microdissection (LCM). LCM samples were pooled from three vaginal tissues, four or five slides per mouse. The images were captured using a 20× objective lens. Scale bars indicate 100 mm. DIC, differential interference contrast.
qRT-PCR analysis of indicated mRNA was performed in CD4 T cells in MLCs and naïve CD4 Tcells that were sorted from spleen (n = 3).Their gene expression was normalized to that of Cd4 for each sample. Data are means T SEM. *P < 0.05; **P < 0.001; ***P < 0.001 (two-tailed unpaired t test).
and accumulated in the lymph nodes after 2 weeks of FTY720 treatment (fig. S5, A and B) (24) , the number of HSV-specific IFN-g + CD4 T cells and K b glycoprotein B (gB) tetramer + CD8 T cells (fig. S5) in the vagina remained unchanged. Thus, MLCs, the main site for CD4 T RM cell residency, are distinct from tertiary lymphoid organs and do not require circulating cells for maintenance.
Next, we compared the ability of tissue-resident versus circulating memory lymphocytes to mediate protection against a lethal HSV-2 challenge using various parabiotic combinations. Mice relying on only the circulating memory cells (group 4) were impaired in their ability to suppress viral replication, and about half of this group succumbed to viral disease, in contrast to the fully protected mice in group 3 that harbor T RM cells (Fig. 2 , A to C, and fig. S6 ). Transient virus control seen in group 4 (first 2 days of challenge) is likely mediated by HSV-2-specific immunoglobulin G (IgG), as previously reported (25, 26) . Protection conferred by the circulating memory cells depended on CD4 + T cells of the immune donor mice (group 5) but not CD8 + T cells (group 6). In addition, IFN-g responsiveness by the cells within the challenged animal was required for protection by WT circulating memory T cells (group 7) (Fig. 2 , A to C, and fig. S6 ). Thus, circulating CD4 memory T cells are able to provide some level of protection against HSV-2 infection and disease, by secreting IFN-g and inhibiting viral replication in the vaginal epithelium, an observation consistent with skin HSV-1 infection (12). However, for complete protection from disease and mortality, local CD4 T RM cells are crucial in providing antiviral defense within the genital mucosa.
Why are circulating memory CD4 T cells inferior to T RM cells? After vaginal infection of the naïve partner with WT HSV-2, circulating T cells from the immunized partner entered the tissue within 2 days (Fig. 2D, filled bars) . However, the newly arriving circulating HSV-2-specific memory CD4 T cells did not secrete IFN-g until 5 days after challenge with HSV-2 ( Fig. 2E) but not an irrelevant virus, influenza (figs. S7 and S8). Because rapid delivery of IFN-g to the vaginal epithelium is crucial in HSV-2 control (27) , this may be why circulating HSV-specific memory CD4 T cells provided poor protection. In contrast, in the presence of MLCs, circulating HSV-2-specific memory T cells were barely recruited upon ivag secondary challenge with viruses ( fig. S8 ). These data indicated that the alarming function of T RM cells (11) might be trumped by the abundance and efficiency of preexisting T RM cells within the MLCs in clearing the secondary infection.
To examine the antigen-specificity of T RM cells, we analyzed the sequence of the CDR3 region of TCRb gene of CD4 T cells isolated from MLCs by laser capture microdissection. Six TCRb CDR3 sequences were shared by CD4 + T cells in MLCs and those in the draining lymph nodes (DLNs) at the peak of primary immune response in TK -HSV-2 immunized mice, but not in naïve mice (Fig. 3A) . One of these sequences, CTCSAAGG-DAEQFF (TCRVb01-01*01 and TCRJb02-01*01) [with variable (V) and joining (J) regions as described], represented a dominant clone (33%) in the CD4 T cells in the MLCs (Fig. 3 , B and C). This dominant clone was also detected in the DLNs and in a portion (11%) of CD4 T cells residing outside of MLCs (Fig. 3, B and C) . Furthermore, we found that HSV-2-specific CD4 T RM cells expressed TCRVb01-01*01 (Fig. 3D and fig. S9 ). These results indicated that MLCs are highly enriched for HSV-2-specific CD4 T RM cells.
We next addressed the mechanism by which T RM neutralizing antibodies against CXCL9 and CCL5. The dose of antibody used was deemed saturating ( fig. S13 ). Blockade of CCL5 diminished the number of HSV-2-specific CD4 T RM and CD8 T RM cells in the vagina (Fig. 4 , B and C, and fig. S12B ) and led to a partial collapse of MLCs ( fig. S14A ). CXCL9 blockade reduced the number of CD8 T RM cells. It is noteworthy that neutralizing CCL5 resulted in diminished protective immune responses to secondary challenge with HSV-2 ivag infection to the level similar to CD4 T cell depletion (Fig. 4C) . Thus, these data indicate that CD4 T RM cells are maintained through continuous interaction with the chemokine CCL5 and that this interaction is required for protection from secondary challenge. Next, we determined the localization and cellular source of CCL5 within the MLC. Five weeks after ivag immunization, CCL5 + cells were mainly localized within MLCs and were maintained for at least 13 weeks ( fig. S14B) S9C were sorted for qPCR analysis of TCR Vb1. Gene expression of these was normalized to that of GAPDH for each sample. TCRBV31  TCRBV29  TCRBV26  TCRBV24  TCRBV23  TCRBV22  TCRBV21  TCR  BV20   TCR  BV19   TCR  BV17   TCRBV16   TCRBV15  TCRBV14  TCRBV13   TCR  BV12   TCR  BV5   TCRBV04   TCRBV03   TCRBV02   TCRBV01  TCRBV31  TCRBV30  TCRBV29  TCRBV26  TCRBV24  TCRBV23  TCRBV22  TCRBV21  TCR  BV20   TCR  BV19   TCRBV17   TCRBV16   TCRBV15  TCRBV14  TCRBV13   TCRBV12   TCRBV05   TCR  BV04   TCR  BV03   TCRBV02   TCRBV01   TCRBV31  TCRBV29  TCRBV26  TCRBV24  TCRBV22  TCRBV20  TCRBV19  TCRBV17  TCRBV16  TCRBV15  TCRBV14   TCRBV13   TCR  BV12   TCRBV05   TCRBV04  TCRBV03   TCRBV02   TCR  BV01   TCRBV29   TCR  BV26   TCR  BV17   TCRBV13  TCRBV12   TCRBV05   TCR  BV03   TCR  BV02   TCRBV01 ( fig. S15, C and F) , and the number of CCL5 + cells increased after immunization (fig. S15E ). Staining for CCL5 was specific ( fig. S15, B and D) . Depletion of CD11b + cells in diphtheria toxin receptorinducible CD11bDTR→WT bone marrow chimera led to a reduction of CCL5 + cells in the vagina (fig. S16, C and D) , complete elimination of MLC structure, and diminished CD4 T RM cells in the vaginal tissue within 5 days (Fig. 4E and fig. S16,  A and B) . Collectively, our results suggest a model in which CD4 T RM cells are maintained through a positive-feedback loop, in which CD4 T RM cell stimulation by local macrophages results in low IFN-g secretion, which in turn induces chemokines, such as CCL5, to retain the T cells within the MLCs. Although there was no detectable viral genomic DNA or mRNA expression in the vagina ( fig. S17) , it remains possible that small amount of viral peptide presentation by MHC II is required for the feedback loop. In support of this hypothesis, single cells were isolated from the vagina in the absence of ex vivo stimulation, and secreted IFN-g was captured onto the cell surface and stained. This uncovered two types of cell populations-those that constitutively express intermediate levels of IFN-g and those that secrete high levels of IFN-g after HSV-2 secondary challenge but not after an irrelevant virus infection (influenza) (fig. S18 ). The majority of the IFN-g int cells (where superscript int indicates intermediate) were CD4 T RM cells (fig. S19, A and  B) and required the presence of CD11b + cells for their IFN-g production (fig. S16F) . In contrast, after WT HSV-2 secondary challenge, antigenpresenting cells that had captured HSV-2 antigen induced the secretion of large amounts of IFN-g by CD4 + T RM cells in an antigen-dependent manner (figs. S18 and S19C). Therefore, these results support a model in which CD4 T RM cells are maintained by chemokines secreted from local macrophages, which are in turn induced by basal levels of IFN-g continuously secreted by T RM cells (fig. S20 ). Upon infection with HSV-2, the CD4 T RM cells are stimulated by cognate antigen to secrete high levels of IFN-g, which results in viral clearance.
Our study highlights the importance of local memory T cells in antiviral defense against genital HSV-2 infection and supports the hypothesis that a local T cell presence correlates with viral control on the basis of human studies (29) (30) (31) . Circulating memory T cells failed to access the genital mucosa at steady state. After infection, whereas circulating memory CD4 T cells do enter the genital tissue and provide protection, viral control is both delayed and incomplete. In contrast, preexisting CD4 T RM cells in the MLCs were able to respond rapidly to secondary challenge and suppressed replication before the virus spread to the nervous system. (red) and CD45, CD11b, or CD11c (green). (E) CD11bDTR into WT bone marrow chimera immunized with TK -HSV-2 5 weeks before were treated with diphtheria toxin, and frozen sections of vaginal tissue were stained with antibodies against CCL5 (red) and CD4 (green). Nuclei are depicted by 4′,6′-diamidino-2-phenylindole (DAPI) stain (blue). Images were captured using a 10× or 40× objective lens. Scale bars indicate 100 mm. These data are representative of three similar experiments. Data are means T SEM. *P < 0.05; **P < 0.001; ***P < 0.001.
which suggests that this may be a common mechanism of adaptive immune defense in the genital mucosa. Our data strongly support the need for designing vaccines for sexually transmitted infections that establish local memory in the T cell pool. + T cells act very locally by contacting infected host cells for both the detection of pathogen-associated peptides presented by major histocompatibility complex class I (MHC-I) and target-cell-specific delivery of toxic effector molecules (2) . After clearance of infection, memory T cells remain. Central, effector, and resident memory T cell subsets (T CM , T EM , and T RM , respectively) occupy different anatomic niches, where they fulfill distinct roles in protective immunity (3, 4). The most recently described subset, T RM , comprises non-recirculating memory T cells that remain positioned at common portals of reinfection, including barrier tissues such as the mucosae and skin (5) (6) (7) (8) (9) (10) . When present at the site of reinfection, T RM cells accelerate protection against homologous reinfections, although the mechanism remains obscure (10) (11) (12) (13) (14) (15) . We recently demonstrated that reactivation of T RM cells results in bystander recruitment of recirculating memory T cells to the site of anamnestic Ag exposure in a manner dependent on the cytokine interferon-g (IFN-g) (16) . This suggested that T RM cells serve a sentinel and alarm function in addition to more prototypical CD8 T cell functions.
We wanted to further understand the mechanism by which CD8 + T RM cells communicated local pathogen-associated antigen reencounter to recirculating memory CD8 T cells located outside the tissue. OT-I or P14 chimeric mice, which contained ovalbumin (OVA)-derived SIINFEKL (E, Glu; F, Phe; I, Ile; K, Lys; L, Leu; N, Asn; S, Ser) or gp33 peptide-specific CD8 + T RM cells, respectively, were established in the female reproductive tract (FRT) as follows: Naïve OT-I or P14 CD8 T cells were transferred intravenously to naïve C57Bl/6J mice, and mice were infected 1 day later with recombinant vaccinia virus expressing OVA (VV-OVA) or lymphocytic choriomeningitis virus (LCMV), respectively ( fig. S1, A and B) . FRT T RM cells were then reactivated locally by depositing cognate SIINFEKL or gp33 peptide into the cervical lumen (transcervical, t.c.), as described (17) . We found that T RM reactivation with either peptide or recombinant vaccinia virus expressing cognate peptide induced expression of the cell adhesion molecule VCAM-1 (vascular cell adhesion molecule-1) on local vascular endothelium (Fig. 1 , A to C). IFN-g is produced by reactivated T RM cells in vivo (16) . We found that exogenous t.c. deposition of IFN-g into naïve mice was sufficient to induce local VCAM-1 expression ( fig. S2 ). Further experiments revealed that when OT-I Ifng −/− T RM cells were reactivated in wild-type mice, VCAM-1 was no longer up-regulated, demonstrating that T RM cells induce local VCAM-1 in a cell-autonomous manner by secreting IFN-g upon antigen resensitization (Fig. 1, A and B) . Additionally, when circulating P14 memory CD8 T cells were depleted (while preserving T RM in the FRT) by injecting 1 mg HIS51 (a Thy1.1-depleting antibody) (16), peptide reactivation resulted in similar levels of VCAM-1 on endothelial cells, suggesting that VCAM-1 expression is driven by local CD8 T cells (Fig. 1D) . VCAM-1 is the ligand for a4b1 integrin, which plays a role in lymphocyte migration (18) . Bystander OT-I CD8 T cell recruitment in response to gp33-specific T RM reactivation was inhibited when either VCAM-1 or a4b1 (CD49d) was blocked with neutralizing antibodies (Fig. 1E) . Because CD8 + T RM cells communicate antigen sensitization to recirculating CD8 T cells through an IFN-g-VCAM-1 axis, we asked whether other lymphocyte lineages might also be recruited. B cells accumulated within the FRT within 12 hours of local CD8 + T RM reactivation and increased >100-fold by 48 hours (Fig. 1,  F and G) . Similar results were observed when recombinant gp33-expressing vaccinia virus was
